The 2026 Cardiology World Congress has officially endorsed the "Leave Nothing Behind" philosophy as the primary approach for elective percutaneous coronary interventions. This shift marks the decline of permanent metallic implants in favor of scaffolds that vanish after the vessel has stabilized. This evolution is particularly relevant for the US heart stent market AI analytics, which...

7 clinical breakthroughs in bioresorbable polymers defining 2026 cardiology As we navigate the first quarter of 2026, the global interventional cardiology landscape is undergoing a tectonic shift toward transient scaffolding. Recent data from the European Society of Cardiology highlights a significant preference for magnesium-based alloys over traditional permanent metallic frames in younger...

  The clinical effectiveness of antiplatelet therapy and the safety of millions of cardiovascular patients worldwide hinge on the generation of highly reliable Platelet Aggregation Devices Market Data. Accurate diagnostic data derived from platelet aggregation devices is the essential input that allows cardiologists and hematologists to make life-saving decisions, primarily concerning the...

The global healthcare industry is witnessing significant growth in cardiovascular treatment solutions as the prevalence of heart-related disorders continues to rise worldwide. Myocardial infarction therapeutics play a critical role in managing acute cardiac events, improving patient survival rates, and reducing long-term cardiovascular complications. The increasing burden of coronary artery...